Novocure Ltd buy melinda
Start price
06.03.18
/
50%
€19.62
Target price
17.04.18
€21.29
Performance (%)
8.85%
End price
17.04.18
€21.35
Summary
This prediction ended on 17.04.18 with a price of €21.35. The BUY prediction by melinda finished with a performance of 8.85%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Novocure Ltd | -6.283% | -6.283% | -10.775% | -86.882% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
Comments by melinda for this prediction
In the thread Novocure Ltd diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 14/05 Ergebnisse Veröffentlichung
$ 21.75
+0,15 (+ 0,69%) Tumor Behandlung Fields (TTFields) - PANOVA 3 Bauchspeicheldrüsenkrebs
Phase 3 2022 2022.12.31 Phase-3-Daten im Jahr 2022 fällig.
(Zielkurs erreicht)